Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats

Circulation

Volumn 90, Issue 6, 1994, Pages 3024-3033

  Levy, Bernard I ^a,b   Duriez, Micheline ^a   Phillipe, Monique ^a   Poitevin, Pierre ^a   Michel, Jean Baptiste ^a  

^a INSERM   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

arteries; collagen; elastin; mechanics; muscle, smooth

Indexed keywords

ALDOSTERONE; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN; DIHYDROPYRIDINE DERIVATIVE; ELASTIN; ISRADIPINE; RENIN;

ALDOSTERONE URINE LEVEL; ANIMAL MODEL; AORTA FLOW; ARTERIAL PRESSURE; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DIURESIS; HEART LEFT VENTRICLE CONTRACTILITY; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HEREDITARY HYPERTENSION; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THORACIC AORTA; VASCULAR RESISTANCE;

EID: 0028658375     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.90.6.3024     Document Type: Article

References (50)

1. Folkow B. Cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension: the fourth Volhard lecture. Clin Sci Mol Med. 1978;55:3S-22S.
2. Wolinsky H. Response of the rat aortic media to hypertension. Circ Res. 1970;26:507-522.
3. Levy BI, Michel JB, Salzmann JL, Azizi M, Poitevin P, Safar ME, Camilleri JP. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res. 1988;63:227-239.
4. Greenwald SE, Berry CL, Ramsey RE. The static mechanical properties and chemical composition of the rat aorta in spontaneously occurring and experimentally induced hypertension: the effect of an anti-hypertensive drug. Br J Exp Pathol. 1985;66: 633-642.
5. Berry CL, Greenwald SE. Effect of hypertension on the static mechanical properties and chemical composition of the rat aorta. Cardiovasc Res. 1976;10:437-451.
6. Levy BI, Benessiano J, Poitevin P, Lukin L, Safar ME. Systemic arterial compliance in normotensive and hypertensive rats. J Cardiovasc Pharmacol. 1985;7:S28-S32.
7. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Circ Res. 1982;51:280-289.
8. Struyker Boudier HAJ, De Mey JG, Smits JFM, Nievelstein HMNW. Hemodynamic actions of calcium entry blockers. Prog Basic Clin Pharmacol. 1989;2:21-66.
9. Safar ME, Simon AC, Levenson JA, Cazor JL. Hemodynamic effects of diltiazem in hypertension. Circ Res. 1983;52(suppl I):I-69-1-73.
10. Yano M, Kumada T, Matsuzaki M, et al. Effect of diltiazem on aortic pressure-diameter relationship in dogs. Am J Physiol. 1989;256:H1580-H1587.
11. Levy BI, El Fertak L, Piedeloup C, Barouki F, Safar ME. Role of endothelium in the mechanical response of the carotid arterial wall to calcium blockade in SHR and WKY rat. J Hypertens. 1993;11:57-63.
12. Nyborg NCB, Mulvany MJ. Lack of effect of antihypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovasc Res. 1985;19:528-536.
13. Aalkjaer C, Eisjaer H, Mulvany MJ. Structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients on antihypertensive treatment. J Hypertens. 1988;7:305-310.
14. Lundin SA, Hallback-Nordlander MIL. Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. J Hypertens. 1984;2:11-18.
15. Pham-Hun-Trung MT, Corvol P. A direct determination of aldosterone. Steroids. 1974;24:587-598.
16. Menard J, Catt KJ. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology. 1972;90:422-430.
17. Benessiano J, Levy BI, Michel JB. Instaneous aortic blood flow measurements with range gated Doppler flowmeter in anesthetized rat. J Pharmacol Methods. 1985;14:99-110.
18. Levy BI, Benessiano J, Poitevin P, Safar ME. Endothelium-dependent mechanical properties of the carotid artery in WKY and SHR: role of angiotensin-converting enzyme inhibition. Circ Res. 1990;66:321-328.
19. Huijberts MSP, Wolffenbuttel BHR, Struyker Boudier HAJ, Crinjs FRL, Nieuwenhuijzen Kruseman AC, Poitevin P, Levy BI. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest. 1993;92: 1407-1411.
20. Tedgui A, Lever MJ. Filtration through damaged and undamaged rabbit thoracic aorta. Am J Physiol. 1984;247:H784-H791.
21. Serra J. Image Analysis and Mathematical Morphology. London: Academic Press Inc; 1982:31-52.
22. Salzmann JL, Azizi M, Michel JB, Camilleri JP. Aortic media structural parameters study using mathematical morphology processor analysis. Acta Stereologica. 1987;6:437-441.
23. Zar JH. Biostatistical Analysis. Englewood, NJ: Prentice-Hall Inc; 1984.
24. 2+ pathway is involved in myogenic tone in resistance artery. Am J Physiol. 1986; 250:H87-H95.
25. Nievelstein HMNW, van Essen H, Tijssen CM, Smits JFM, Struyker-Boudier HAJ. Systemic and regional actions of calcium entry blockers in conscious spontaneously hypertensive rats. Eur J Pharmacol. 1985;113:187-198.
26. Cody RJ. The hemodynamics of calcium channel antagonists in hypertension: vascular and myocardial responses. Circulation. 1987;75:1175-1179.
27. Majid PA, De Jong J. Acute hemodynamic effects of nifedipine in patients with ischemic heart disease. Circulation. 1982;65:1114-1118.
28. Fagard R, Lijnen P, Moerman E, Staessen J, Amery A. Acute hemodynamic and humoral responses to felodipinc and metoprolol in mild hypertension. Eur J Clin Pharmacol. 1987;32:71-75.
29. Lambert CR, Hill JA, Nichols WW, Feldjnan RL, Pepine CJ. Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol. 1985;55:652-656.
30. Silke B, Frais MA, Muller P, Verma SP, Reynolds G, Taylor SH. Hemodynamic dose-response effects of intravenous nisoldipine in coronary heart disease. Br J Clin Pharmacol. 1985;20:675-680.
31. Nordlander M, Di Bona GF, Ljung B, Yao T, Thoren P. Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR. Eur J Pharmacol. 1985;113:25-36.
32. Kobrin I, Sesoko S, Pegram BL, Frohlich ED. Reduced cardiac mass by nitrendipine is associated from systemic or regional hemodynamic changes rats. Cardiovasc Res. 1984;18:158-162.
33. Natsume T, Gallo AJ, Pegram BL, Frohlich ED. Hemodynamic effects of prolonged treatment with diltiazem in conscious normotensive and spontaneously hypertensive rats. Clin Exp Hypertens'. 1985;A7:1471-1479.
34. Ljung B. Vascular selectivity of felodipine. Drugs. 1985;29(suppl 2): 46-58.
35. Chiu JH. Differential sensitivity of calcium channels to dihydropyridines: the modulated receptor hypothesis. Biochem Pharmacol. 1986;35:4115-4120.
36. Campbell BC, Kelman AW, Hillis WS. Non-invasive assessment of the hemodynamic effects of nicardipine in normotensive subjects. Br J Clin Pharmacol. 1985;20:55-61.
37. Katayama S, Abe M, Inaba M, Maruno Y, Itabashi A, Ishii J. Hypertension. 1991;18:399. Abstract.
38. Luft FC, Aronoff GR, Sloan RS, Fineberg NS, Weinberger MH. Calcium channel blockade with nitrendipine. Hypertension. 1985; 7:438-442.
39. Kojima K, Kojima I, Rasmussen H. Dihydropyridine calcium agonist and antagonist effects on aldosterone secretion. Am J Physiol. 1984;247:E645-E650.
40. Arcaro G, Laurent S, Jondeau G, Hoeks AP, Safar ME. Stiffness of the common carotid artery in treated hypertensive patients. J Hypertens. 1991;9:947-954.
41. Nichols WW, O'Rourke MF. Vascular impedance. In: McDonald's Blood Flow in Arteries: Theoretic, Experimental and Clinical Principles, ed 3. London: Edward Arnold Publishers; 1991:283-329.
42. Thuillez C, Gueret M, Duhaze P, Lhoste F, Kiechel JR, Giudicelli JF. Nicardipine: pharmacokinetics and effects on carotid and brachial blood flow in normal volunteers. Br J Clin Pharmacol. 1984;18:837-847.
43. Bouthier JD, Safar ME, Benetos A, Simon AC, Levenson JA, Hugues CM. Haemodynamic effects of vasodilating drugs on the common carotid and brachial circulations of patients with essential hypertension. Br J Clin Pharmacol. 1986;21:137-142.
44. Levenson JA, Simon AC, Bouthier J, Safar ME. The effect of acute and chronic nicardipine therapy on forearm arterial hemodynamics in essential hypertension. Br J Pharmacol. 1985;20:107-113.
45. Olivetti G, Anversa P, Melissari M, Loud AV. Morphometry of medial hypertrophy in the rat thoracic aorta. Lab Invest. 1980;42: 559-565.
46. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Circ Res. 1982;51: 280-289.
47. Mourlon Le-Grand MC, Poitevin P, Benessiano J, Duriez M, Michel JB, Levy BI. Effect of a nonhypotensive long-term infusion of ANP on the mechanical and structural properties of the arterial wall in Wistar-Kyoto and spontaneously hypertensive rats. Arte-rioscler Thromb. 1993;13:640-650.
48. Berk BC, Vekshtein V, Gordon HM, Terutaka T. Angiotensin II-stimulated protein synthesis in cultured aortic smooth muscle cells. Hypertension. 1989;13:305-314.
49. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a nonpressor mechanism. Hypertension. 1991;17:626-635.
50. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-22.